Bagsværd, Denmark, 21 May 2021 - Novo Nordisk A/S today announced that Novo Nordisk has established a Euro Medium Term Note (EMTN) programme. The programme provides a framework for Novo Nordisk to complete issuances of senior unsecured notes up to an aggregated total amount of EUR 5 billion. The details of the programme are outlined below:

Issuer:

 

Novo Nordisk A/S or Novo Nordisk Finance (Netherlands) B.V.

Guarantor:

 

Novo Nordisk A/S

Programme size:

 

EUR 5,000,000,000

Arranger:

 

Citigroup

Dealers:

 

Citigroup, Danske Bank, Deutsche Bank, Handelsbanken Capital Markets, HSBC, ING, J.P. Morgan, MUFG, Morgan Stanley, Nordea, Nykredit Bank A/S, SEB

Prospectus:

 

EUR 5,000,000,000 EMTN Programme dated 20 May 2021


Read the press release

Read the prospectus

Issuer:

 

Novo Nordisk Finance (Netherlands) B.V.

Amount:

 

EUR 650 million

Coupon:

 

0%

Issue date:

 

4 June 2021

Maturity:

 

4 June 2024

 

Issuer:

 

Novo Nordisk Finance (Netherlands) B.V.

Amount:

 

EUR 650 million

Coupon:

 

0.125%

Issue date:

 

4 June 2021

Maturity:

 

4 June 2028

 

Read the press release